Pieris Pharmaceuticals Second Quarter 2024 Earnings US2.76 loss per share
Slightly above 67% of PIRS Old's investor base is looking to short. The analysis of current outlook of investing in PIRS Old suggests that many traders are alarmed regarding PIRS Old's prospects. PIRS Old's investing sentiment can be driven by a variety of factors including economic data, PIRS Old's earnings reports, geopolitical events, and overall market trends.
PIRS |
Pieris Pharmaceuticals Second Quarter 2024 Results Key Financial Results Net loss US3.59m down by...
Read at finance.yahoo.com
 |
PIRS Old Fundamental Analysis
We analyze PIRS Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PIRS Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PIRS Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
PIRS Old is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
PIRS Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PIRS Old stock to make a market-neutral strategy. Peer analysis of PIRS Old could also be used in its relative valuation, which is a method of valuing PIRS Old by comparing valuation metrics with similar companies.
Peers
PIRS Old Related Equities
| LPTX | Leap Therapeutics | 5.56 | ||||
| CRVS | Corvus Pharmaceuticals | 5.16 | ||||
| ADAP | Adaptimmune Therapeutics | 3.70 | ||||
| ADCT | ADC Therapeutics | 2.88 | ||||
| TERN | Terns Pharmaceuticals | 2.72 | ||||
| AGEN | Agenus | 0.79 | ||||
| CKPT | Checkpoint Therapeutics | 0.48 | ||||
| INZY | Inozyme Pharma | 0.25 | ||||
| MREO | Mereo BioPharma | 1.75 | ||||
| XFOR | X4 Pharmaceuticals | 4.02 | ||||
| CUE | Cue Biopharma | 7.04 | ||||
| PDSB | PDS Biotechnology | 9.49 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in PIRS Stock
If you are still planning to invest in PIRS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PIRS Old's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |